The panel, due to report by 18 November 2026, will assess funding design options for the only remaining mainland Australian state relying on an insurance-based levy.
The Hong Kong non-life insurer's A (Excellent) rating and stable outlook remain intact as strong capitalisation and rising investment returns offset a soft, competitive market.